Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDARAVONE vs EFALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EDARAVONE vs EFALIZUMAB: Safety Overview

Metric EDARAVONE EFALIZUMAB
Total FAERS Reports 3,762 230
Deaths Reported 1,137 73
Death Rate 30.2% 31.7%
Hospitalizations 495 44
Average Patient Age 65.0 yrs 52.3 yrs
% Female Patients 41.5% 46.2%
FDA Approval Date Dec 23, 2024 N/A
Manufacturer Gland Pharma Limited N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A